BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?
BridgeBio Pharma Ownership Summary
BridgeBio Pharma is owned by 91.71% institutional investors, 2.92% insiders, and 5.37% retail investors. Kohlberg kravis roberts is the largest institutional shareholder, holding 13.40% of BBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.54% of its assets in BridgeBio Pharma shares.
BBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BridgeBio Pharma | 91.71% | 2.92% | 5.37% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Kohlberg kravis roberts | 25.26M | 13.40% | $693.16M |
| Viking global investors lp | 25.12M | 13.33% | $689.32M |
| Vanguard group | 15.08M | 8.00% | $413.74M |
| Blackrock funding, inc. /de | 13.71M | 7.27% | $376.19M |
| Blackrock | 12.45M | 6.64% | $315.31M |
| State street | 6.18M | 3.28% | $169.65M |
| Aisling capital management lp | 6.07M | 3.22% | $166.51M |
| Janus henderson group | 4.91M | 2.60% | $134.67M |
| Farallon capital management | 4.20M | 2.23% | $115.11M |
| Laurion capital management lp | 3.74M | 1.98% | $102.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aisling capital management lp | 6.07M | 59.08% | $166.51M |
| Kohlberg kravis roberts | 25.26M | 18.56% | $693.16M |
| Prosight management, lp | 995.00K | 7.55% | $27.30M |
| Cutter capital management, lp | 560.34K | 6.30% | $15.38M |
| Superstring capital management lp | 262.14K | 6.23% | $7.19M |
| Lion point capital, lp | 40.30K | 5.79% | $1.11M |
| Exome asset management | 246.70K | 5.09% | $6.77M |
| Sphera funds management | 905.28K | 4.49% | $24.84M |
| Frazier life sciences management | 3.63M | 4.30% | $92.01M |
| Adar1 capital management | 678.86K | 3.72% | $18.63M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Farallon capital management | 4.20M | 0.58% | 2.45M |
| Blackrock | 12.45M | 0.01% | 1.98M |
| Woodline partners lp | 2.21M | 0.41% | 1.26M |
| Norges bank | 1.07M | 0.00% | 1.07M |
| Alyeska investment group | 940.41K | 0.10% | 940.41K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lord, abbett | - | - | -2.80M |
| Perceptive advisors | - | - | -1.22M |
| Paradigm biocapital advisors lp | - | - | -1.09M |
| Pictet asset management sa | 1.81M | 0.05% | -995.59K |
| Jpmorgan chase | 299.21K | 0.00% | -916.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.07M | 0.00% | 1.07M | $29.24M |
| Alyeska investment group | 940.41K | 0.10% | 940.41K | $25.80M |
| Deep track capital, lp | 819.16K | 0.84% | 819.16K | $22.48M |
| Pfm health sciences, lp | 290.24K | 0.49% | 290.24K | $7.96M |
| Susquehanna fundamental investments | 238.00K | 0.09% | 238.00K | $6.53M |
Sold Out
| Holder | Change |
|---|---|
| Creekmur asset management | -3.00 |
| Financial gravity asset management | -3.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Continuum advisory | -34.00 |
| Srs capital advisors | -51.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 304 | 8.57% | 172,882,432 | 0.83% | 91 | 1.11% | 155 | 6.90% | 78 | 1.30% |
| Sep 30, 2024 | 278 | -2.11% | 171,231,529 | -1.98% | 90 | 1.05% | 147 | -3.29% | 74 | 2.78% |
| Jun 30, 2024 | 284 | 1.43% | 174,683,428 | 2.52% | 93 | 1.02% | 152 | 11.76% | 72 | -15.29% |
| Mar 31, 2024 | 280 | 3.32% | 170,388,909 | 3.05% | 95 | 0.92% | 136 | -5.56% | 85 | 8.97% |
| Dec 31, 2023 | 271 | 10.16% | 165,339,966 | 3.06% | 101 | 1.05% | 144 | 19.01% | 78 | 1.30% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.84M | 2.54% | 3.12K |
| Vanguard US Total Market Shares ETF | 4.53M | 2.38% | 3.92K |
| Vanguard Small Cap Index | 3.86M | 2.03% | 3.15K |
| iShares Russell 2000 ETF | 3.70M | 1.94% | -32.01K |
| SPDR® S&P Biotech ETF | 2.48M | 1.30% | -26.54K |
| American Funds SMALLCAP World A | 2.46M | 1.30% | 750.00K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.24M | 1.18% | 10.95K |
| Vanguard Small Cap Growth Index Inv | 2.17M | 1.14% | -12.05K |
| T. Rowe Price Integrated US SmCapGrEq | 1.38M | 0.73% | 818.56K |
| Fidelity Small Cap Index | 1.39M | 0.73% | -25.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2025 | Ellis Andrea | - | Sell | $1.02M |
| Mar 25, 2025 | Kumar Neil | Chief Executive Officer | Sell | $2.76M |
| Mar 06, 2025 | Valantine Hannah | - | Sell | $419.50K |
| Mar 05, 2025 | KKR Genetic Disorder L.P. | - | Sell | $197.76M |
| Feb 25, 2025 | STEPHENSON BRIAN C | CFO and Treasurer | Sell | $278.70K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 15 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 3 |
BBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools